FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

421026006: Conventional release oral tablet (dose form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2616657012 Oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3636015013 Conventional release oral tablet (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3636016014 Conventional release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release oral tablet Is a Tablet false Inferred relationship Existential restriction modifier
Conventional release oral tablet Is a Oral dose form true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form intended site Oral true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form administration method Swallow true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release oral tablet Has basic dose form Tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lisinopril 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lisinopril 2.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lisinopril 20mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lisinopril 5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lofepramine 70mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Loperamide 2mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Loratadine 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lorazepam 1mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lorazepam 2.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lormetazepam 500microgram tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lormetazepam 1mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 100mg / Hydrochlorothiazide 25mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 100mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 25mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Losartan 50mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Capecitabine 150mg tablets (medac UK) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Capecitabine 500mg tablets (medac UK) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mebeverine 135mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Meloxicam 15mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Meloxicam 7.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Memantine 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metformin 500mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metformin 850mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methotrexate 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methotrexate 2.5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methyldopa 500mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methylphenidate 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methylphenidate 20mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methylphenidate 5mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metoclopramide 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metoprolol 100mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metoprolol 50mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metronidazole 200mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metronidazole 400mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metronidazole 500mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mianserin 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mianserin 30mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Minocycline 100mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Minocycline 50mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mirtazapine 15mg orodispersible tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin 250mg gastro-resistant tablets (Bristol Laboratories Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Bristol Laboratories Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Methyldopa 500mg tablets (Bristol Laboratories Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Paracetamol 500mg caplets (Bristol Laboratories Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Spironolactone 100mg tablets (Bristol Laboratories Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Spironolactone 25mg tablets (Bristol Laboratories Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Numark Constipation Relief 5mg gastro-resistant tablets (Numark Management Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mirtazapine 30mg orodispersible tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mirtazapine 15mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mirtazapine 30mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mirtazapine 45mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moclobemide 150mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moclobemide 300mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Modafinil 100mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Modafinil 200mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Montelukast 10mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moxonidine 200microgram tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moxonidine 300microgram tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Mycophenolate mofetil 500mg tablets (DE Pharmaceuticals) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Raloxifene 60mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Actelsar HCT 40mg/12.5mg tablets (Actavis UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Actelsar HCT 80mg/12.5mg tablets (Actavis UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Pyridoxine 10mg tablets (CST Pharma Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nebivolol 10mg tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Ribavirin 200mg tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Tibolone 2.5mg tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cetirizine 10mg tablets (Bell,Sons & Co (Druggists) Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Telmisartan 40mg / Hydrochlorothiazide 12.5mg tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Telmisartan 20mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Telmisartan 40mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Telmisartan 80mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nebivolol 5mg tablets (Almus Pharmaceuticals Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metolazone 2.5mg tablets (Special Order) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Metolazone 5mg tablets (Special Order) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Azathioprine 25mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Candesartan 4mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Candesartan 8mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Candesartan 16mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Candesartan 32mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Lamivudine 100mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets (Teva UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Montelukast 10mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Sildenafil 25mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Sildenafil 50mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Sildenafil 100mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Tolterodine 1mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Tolterodine 2mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Zolmitriptan 2.5mg tablets (Sandoz Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Cilostazol 50mg tablets (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Tolura 20mg tablets (Krka UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Tolura 40mg tablets (Krka UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Tolura 80mg tablets (Krka UK Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Raloxifene 60mg tablets (Accord Healthcare Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier
Capecitabine 150mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form True Conventional release oral tablet Inferred relationship Existential restriction modifier

Start Previous Page 316 of 345 Next End


This concept is not in any reference sets

Back to Start